Business and Economy

A New Frontier in Oncology: FDA Approves Rasonque, Shattering the ‘Undruggable’ Barrier in Pancreatic Cancer

In a landmark decision that signals a paradigm shift in the treatment of one of the world’s most lethal malignancies,...

Health and Wellness

Engineering the "Trojan Horse": How Engineered Probiotics Are Turning the Tide Against Pancreatic Cancer

Pancreatic cancer has long been considered one of the most formidable adversaries in oncology. Characterized by its aggressive nature and...

Health and Wellness

A New Frontier in Oncology: Researchers Identify Novel Compounds to Neutralize Lethal Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) has long remained one of the most formidable adversaries in clinical oncology. Characterized by its late...